Volume 24, Number 4—April 2018
Carbapenem-Nonsusceptible Acinetobacter baumannii, 8 US Metropolitan Areas, 2012–2015
|Hospitalized at, or within 30 d after, date of specimen collection, n = 598||449 (75.1)|
|Admission to intensive care unit on day of or within 7 d after sample collection, n = 449||168 (37.4)|
|Discharge location after acute care hospitalization among patients who survived, n = 356†|
|Long-term care facility||187 (52.5))|
|Private residence||131 (36.8)|
|Long-term acute care hospital||34 (9.6))|
|| 1 (0.3)
|Died,‡ n = 594||106 (17.9)|
|Among cases with a sterile site culture, n = 172§||71 (41.3)|
|Among cases with a positive urine culture, n = 422§||35 (8.3)|
*The study areas were Denver, Colorado; Atlanta, Georgia; Baltimore, Maryland; Minneapolis/Saint Paul, Minnesota, Albuquerque, New Mexico; Rochester, New York; Portland, Oregon; Nashville, Tennessee.
†Three case-patients were discharged to unknown locations.
‡Death was determined at discharge for hospital inpatients; 30 d after sample collection for case-patients identified in outpatient dialysis, long-term care, and long-term acute care hospitals; and at evaluation for outpatients. For 4 case-patients, outcome was unknown. The 1 patient who had a blood sampel and a urine was counted in the “sterile site culture” category.
§Significant difference in death by specimen source (p<0.0001).